Figure 2
Kaplan–Meier analysis of overall survival in GC patients with high or low serum SDF4 levels based on the median serum level. The number at risk every 12 months is shown at the bottom of the figure.
Figure 2 | Scientific Reports
Kaplan–Meier analysis of overall survival in GC patients with high or low serum SDF4 levels based on the median serum level. The number at risk every 12 months is shown at the bottom of the figure.
